ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Personalized Medicine for Cancer Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-24X11317
Home | Market Reports | Health| Health Conditions| Cancer
Global Personalized Medicine for Cancer Market Research Report 2022
BUY CHAPTERS

Global Personalized Medicine for Cancer Market Research Report 2025

Code: QYRE-Auto-24X11317
Report
January 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
GlaxoSmithKline PLC
Novartis
Sanofi
Pfizer Inc
Amgen Inc
Merck
Bristol–Myers Squibb
ARIAD Pharmaceuticals (Takeda)
Eli Lilly
Roche
Boehringer Ingelheim
Johnson and Johnson
Teva Pharmaceuticals

Personalized Medicine for Cancer Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Personalized Medicine for Cancer Market

Personalized Medicine for Cancer Market

The global market for Personalized Medicine for Cancer was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Personalized Medicine for Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Medicine for Cancer.
The Personalized Medicine for Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Personalized Medicine for Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Personalized Medicine for Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Personalized Medicine for Cancer Market Report

Report Metric Details
Report Name Personalized Medicine for Cancer Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer, GlaxoSmithKline, Novartis, Sanofi, Pfizer, Amgen, Merck, Bristol-Myers Squibb, Ariad Pharmaceuticals (Takeda), Eli Lilly, Roche, Boehringer Ingelheim, Johnson and Johnson, Teva Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Personalized Medicine for Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Personalized Medicine for Cancer Market report?

Ans: The main players in the Personalized Medicine for Cancer Market are Bayer, GlaxoSmithKline, Novartis, Sanofi, Pfizer, Amgen, Merck, Bristol-Myers Squibb, Ariad Pharmaceuticals (Takeda), Eli Lilly, Roche, Boehringer Ingelheim, Johnson and Johnson, Teva Pharmaceuticals

What are the Application segmentation covered in the Personalized Medicine for Cancer Market report?

Ans: The Applications covered in the Personalized Medicine for Cancer Market report are Breast Cancer, Blood Cancer, Gastrointestinal Cancer, Prostate Cancer, Skin Cancer, Lung Cancer, Others

What are the Type segmentation covered in the Personalized Medicine for Cancer Market report?

Ans: The Types covered in the Personalized Medicine for Cancer Market report are Immunotherapy, Targeted Therapy, Chemotherapy, Hormone Therapy, Others

Recommended Reports

Cancer Diagnostics

Cancer Therapeutics

Cancer Specialty Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicine for Cancer Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunotherapy
1.2.3 Targeted Therapy
1.2.4 Chemotherapy
1.2.5 Hormone Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Personalized Medicine for Cancer Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Blood Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Skin Cancer
1.3.7 Lung Cancer
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Medicine for Cancer Market Perspective (2020-2031)
2.2 Global Personalized Medicine for Cancer Growth Trends by Region
2.2.1 Global Personalized Medicine for Cancer Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Personalized Medicine for Cancer Historic Market Size by Region (2020-2025)
2.2.3 Personalized Medicine for Cancer Forecasted Market Size by Region (2026-2031)
2.3 Personalized Medicine for Cancer Market Dynamics
2.3.1 Personalized Medicine for Cancer Industry Trends
2.3.2 Personalized Medicine for Cancer Market Drivers
2.3.3 Personalized Medicine for Cancer Market Challenges
2.3.4 Personalized Medicine for Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Medicine for Cancer Players by Revenue
3.1.1 Global Top Personalized Medicine for Cancer Players by Revenue (2020-2025)
3.1.2 Global Personalized Medicine for Cancer Revenue Market Share by Players (2020-2025)
3.2 Global Personalized Medicine for Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Personalized Medicine for Cancer Revenue
3.4 Global Personalized Medicine for Cancer Market Concentration Ratio
3.4.1 Global Personalized Medicine for Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicine for Cancer Revenue in 2024
3.5 Global Key Players of Personalized Medicine for Cancer Head office and Area Served
3.6 Global Key Players of Personalized Medicine for Cancer, Product and Application
3.7 Global Key Players of Personalized Medicine for Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicine for Cancer Breakdown Data by Type
4.1 Global Personalized Medicine for Cancer Historic Market Size by Type (2020-2025)
4.2 Global Personalized Medicine for Cancer Forecasted Market Size by Type (2026-2031)
5 Personalized Medicine for Cancer Breakdown Data by Application
5.1 Global Personalized Medicine for Cancer Historic Market Size by Application (2020-2025)
5.2 Global Personalized Medicine for Cancer Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Personalized Medicine for Cancer Market Size (2020-2031)
6.2 North America Personalized Medicine for Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Personalized Medicine for Cancer Market Size by Country (2020-2025)
6.4 North America Personalized Medicine for Cancer Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Medicine for Cancer Market Size (2020-2031)
7.2 Europe Personalized Medicine for Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Personalized Medicine for Cancer Market Size by Country (2020-2025)
7.4 Europe Personalized Medicine for Cancer Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Medicine for Cancer Market Size (2020-2031)
8.2 Asia-Pacific Personalized Medicine for Cancer Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Personalized Medicine for Cancer Market Size by Region (2020-2025)
8.4 Asia-Pacific Personalized Medicine for Cancer Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Medicine for Cancer Market Size (2020-2031)
9.2 Latin America Personalized Medicine for Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Personalized Medicine for Cancer Market Size by Country (2020-2025)
9.4 Latin America Personalized Medicine for Cancer Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Medicine for Cancer Market Size (2020-2031)
10.2 Middle East & Africa Personalized Medicine for Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Personalized Medicine for Cancer Market Size by Country (2020-2025)
10.4 Middle East & Africa Personalized Medicine for Cancer Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Personalized Medicine for Cancer Introduction
11.1.4 Bayer Revenue in Personalized Medicine for Cancer Business (2020-2025)
11.1.5 Bayer Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Personalized Medicine for Cancer Introduction
11.2.4 GlaxoSmithKline Revenue in Personalized Medicine for Cancer Business (2020-2025)
11.2.5 GlaxoSmithKline Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Personalized Medicine for Cancer Introduction
11.3.4 Novartis Revenue in Personalized Medicine for Cancer Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Personalized Medicine for Cancer Introduction
11.4.4 Sanofi Revenue in Personalized Medicine for Cancer Business (2020-2025)
11.4.5 Sanofi Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Personalized Medicine for Cancer Introduction
11.5.4 Pfizer Revenue in Personalized Medicine for Cancer Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Personalized Medicine for Cancer Introduction
11.6.4 Amgen Revenue in Personalized Medicine for Cancer Business (2020-2025)
11.6.5 Amgen Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Personalized Medicine for Cancer Introduction
11.7.4 Merck Revenue in Personalized Medicine for Cancer Business (2020-2025)
11.7.5 Merck Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Personalized Medicine for Cancer Introduction
11.8.4 Bristol-Myers Squibb Revenue in Personalized Medicine for Cancer Business (2020-2025)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Ariad Pharmaceuticals (Takeda)
11.9.1 Ariad Pharmaceuticals (Takeda) Company Details
11.9.2 Ariad Pharmaceuticals (Takeda) Business Overview
11.9.3 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Introduction
11.9.4 Ariad Pharmaceuticals (Takeda) Revenue in Personalized Medicine for Cancer Business (2020-2025)
11.9.5 Ariad Pharmaceuticals (Takeda) Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Personalized Medicine for Cancer Introduction
11.10.4 Eli Lilly Revenue in Personalized Medicine for Cancer Business (2020-2025)
11.10.5 Eli Lilly Recent Development
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Personalized Medicine for Cancer Introduction
11.11.4 Roche Revenue in Personalized Medicine for Cancer Business (2020-2025)
11.11.5 Roche Recent Development
11.12 Boehringer Ingelheim
11.12.1 Boehringer Ingelheim Company Details
11.12.2 Boehringer Ingelheim Business Overview
11.12.3 Boehringer Ingelheim Personalized Medicine for Cancer Introduction
11.12.4 Boehringer Ingelheim Revenue in Personalized Medicine for Cancer Business (2020-2025)
11.12.5 Boehringer Ingelheim Recent Development
11.13 Johnson and Johnson
11.13.1 Johnson and Johnson Company Details
11.13.2 Johnson and Johnson Business Overview
11.13.3 Johnson and Johnson Personalized Medicine for Cancer Introduction
11.13.4 Johnson and Johnson Revenue in Personalized Medicine for Cancer Business (2020-2025)
11.13.5 Johnson and Johnson Recent Development
11.14 Teva Pharmaceuticals
11.14.1 Teva Pharmaceuticals Company Details
11.14.2 Teva Pharmaceuticals Business Overview
11.14.3 Teva Pharmaceuticals Personalized Medicine for Cancer Introduction
11.14.4 Teva Pharmaceuticals Revenue in Personalized Medicine for Cancer Business (2020-2025)
11.14.5 Teva Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Bayer
GlaxoSmithKline PLC
Novartis
Sanofi
Pfizer Inc
Amgen Inc
Merck
Bristol–Myers Squibb
ARIAD Pharmaceuticals (Takeda)
Eli Lilly
Roche
Boehringer Ingelheim
Johnson and Johnson
Teva Pharmaceuticals
List of Tables
 Table 1. Global Personalized Medicine for Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Immunotherapy
 Table 3. Key Players of Targeted Therapy
 Table 4. Key Players of Chemotherapy
 Table 5. Key Players of Hormone Therapy
 Table 6. Key Players of Others
 Table 7. Global Personalized Medicine for Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Personalized Medicine for Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Personalized Medicine for Cancer Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Personalized Medicine for Cancer Market Share by Region (2020-2025)
 Table 11. Global Personalized Medicine for Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Personalized Medicine for Cancer Market Share by Region (2026-2031)
 Table 13. Personalized Medicine for Cancer Market Trends
 Table 14. Personalized Medicine for Cancer Market Drivers
 Table 15. Personalized Medicine for Cancer Market Challenges
 Table 16. Personalized Medicine for Cancer Market Restraints
 Table 17. Global Personalized Medicine for Cancer Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Personalized Medicine for Cancer Market Share by Players (2020-2025)
 Table 19. Global Top Personalized Medicine for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine for Cancer as of 2024)
 Table 20. Ranking of Global Top Personalized Medicine for Cancer Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Personalized Medicine for Cancer Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Personalized Medicine for Cancer, Headquarters and Area Served
 Table 23. Global Key Players of Personalized Medicine for Cancer, Product and Application
 Table 24. Global Key Players of Personalized Medicine for Cancer, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Personalized Medicine for Cancer Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Personalized Medicine for Cancer Revenue Market Share by Type (2020-2025)
 Table 28. Global Personalized Medicine for Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Personalized Medicine for Cancer Revenue Market Share by Type (2026-2031)
 Table 30. Global Personalized Medicine for Cancer Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Personalized Medicine for Cancer Revenue Market Share by Application (2020-2025)
 Table 32. Global Personalized Medicine for Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Personalized Medicine for Cancer Revenue Market Share by Application (2026-2031)
 Table 34. North America Personalized Medicine for Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Personalized Medicine for Cancer Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Personalized Medicine for Cancer Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Personalized Medicine for Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Personalized Medicine for Cancer Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Personalized Medicine for Cancer Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Personalized Medicine for Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Personalized Medicine for Cancer Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Personalized Medicine for Cancer Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Personalized Medicine for Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Personalized Medicine for Cancer Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Personalized Medicine for Cancer Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Personalized Medicine for Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Personalized Medicine for Cancer Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Personalized Medicine for Cancer Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Bayer Company Details
 Table 50. Bayer Business Overview
 Table 51. Bayer Personalized Medicine for Cancer Product
 Table 52. Bayer Revenue in Personalized Medicine for Cancer Business (2020-2025) & (US$ Million)
 Table 53. Bayer Recent Development
 Table 54. GlaxoSmithKline Company Details
 Table 55. GlaxoSmithKline Business Overview
 Table 56. GlaxoSmithKline Personalized Medicine for Cancer Product
 Table 57. GlaxoSmithKline Revenue in Personalized Medicine for Cancer Business (2020-2025) & (US$ Million)
 Table 58. GlaxoSmithKline Recent Development
 Table 59. Novartis Company Details
 Table 60. Novartis Business Overview
 Table 61. Novartis Personalized Medicine for Cancer Product
 Table 62. Novartis Revenue in Personalized Medicine for Cancer Business (2020-2025) & (US$ Million)
 Table 63. Novartis Recent Development
 Table 64. Sanofi Company Details
 Table 65. Sanofi Business Overview
 Table 66. Sanofi Personalized Medicine for Cancer Product
 Table 67. Sanofi Revenue in Personalized Medicine for Cancer Business (2020-2025) & (US$ Million)
 Table 68. Sanofi Recent Development
 Table 69. Pfizer Company Details
 Table 70. Pfizer Business Overview
 Table 71. Pfizer Personalized Medicine for Cancer Product
 Table 72. Pfizer Revenue in Personalized Medicine for Cancer Business (2020-2025) & (US$ Million)
 Table 73. Pfizer Recent Development
 Table 74. Amgen Company Details
 Table 75. Amgen Business Overview
 Table 76. Amgen Personalized Medicine for Cancer Product
 Table 77. Amgen Revenue in Personalized Medicine for Cancer Business (2020-2025) & (US$ Million)
 Table 78. Amgen Recent Development
 Table 79. Merck Company Details
 Table 80. Merck Business Overview
 Table 81. Merck Personalized Medicine for Cancer Product
 Table 82. Merck Revenue in Personalized Medicine for Cancer Business (2020-2025) & (US$ Million)
 Table 83. Merck Recent Development
 Table 84. Bristol-Myers Squibb Company Details
 Table 85. Bristol-Myers Squibb Business Overview
 Table 86. Bristol-Myers Squibb Personalized Medicine for Cancer Product
 Table 87. Bristol-Myers Squibb Revenue in Personalized Medicine for Cancer Business (2020-2025) & (US$ Million)
 Table 88. Bristol-Myers Squibb Recent Development
 Table 89. Ariad Pharmaceuticals (Takeda) Company Details
 Table 90. Ariad Pharmaceuticals (Takeda) Business Overview
 Table 91. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Product
 Table 92. Ariad Pharmaceuticals (Takeda) Revenue in Personalized Medicine for Cancer Business (2020-2025) & (US$ Million)
 Table 93. Ariad Pharmaceuticals (Takeda) Recent Development
 Table 94. Eli Lilly Company Details
 Table 95. Eli Lilly Business Overview
 Table 96. Eli Lilly Personalized Medicine for Cancer Product
 Table 97. Eli Lilly Revenue in Personalized Medicine for Cancer Business (2020-2025) & (US$ Million)
 Table 98. Eli Lilly Recent Development
 Table 99. Roche Company Details
 Table 100. Roche Business Overview
 Table 101. Roche Personalized Medicine for Cancer Product
 Table 102. Roche Revenue in Personalized Medicine for Cancer Business (2020-2025) & (US$ Million)
 Table 103. Roche Recent Development
 Table 104. Boehringer Ingelheim Company Details
 Table 105. Boehringer Ingelheim Business Overview
 Table 106. Boehringer Ingelheim Personalized Medicine for Cancer Product
 Table 107. Boehringer Ingelheim Revenue in Personalized Medicine for Cancer Business (2020-2025) & (US$ Million)
 Table 108. Boehringer Ingelheim Recent Development
 Table 109. Johnson and Johnson Company Details
 Table 110. Johnson and Johnson Business Overview
 Table 111. Johnson and Johnson Personalized Medicine for Cancer Product
 Table 112. Johnson and Johnson Revenue in Personalized Medicine for Cancer Business (2020-2025) & (US$ Million)
 Table 113. Johnson and Johnson Recent Development
 Table 114. Teva Pharmaceuticals Company Details
 Table 115. Teva Pharmaceuticals Business Overview
 Table 116. Teva Pharmaceuticals Personalized Medicine for Cancer Product
 Table 117. Teva Pharmaceuticals Revenue in Personalized Medicine for Cancer Business (2020-2025) & (US$ Million)
 Table 118. Teva Pharmaceuticals Recent Development
 Table 119. Research Programs/Design for This Report
 Table 120. Key Data Information from Secondary Sources
 Table 121. Key Data Information from Primary Sources
 Table 122. Authors List of This Report


List of Figures
 Figure 1. Personalized Medicine for Cancer Picture
 Figure 2. Global Personalized Medicine for Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Personalized Medicine for Cancer Market Share by Type: 2024 VS 2031
 Figure 4. Immunotherapy Features
 Figure 5. Targeted Therapy Features
 Figure 6. Chemotherapy Features
 Figure 7. Hormone Therapy Features
 Figure 8. Others Features
 Figure 9. Global Personalized Medicine for Cancer Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Personalized Medicine for Cancer Market Share by Application: 2024 VS 2031
 Figure 11. Breast Cancer Case Studies
 Figure 12. Blood Cancer Case Studies
 Figure 13. Gastrointestinal Cancer Case Studies
 Figure 14. Prostate Cancer Case Studies
 Figure 15. Skin Cancer Case Studies
 Figure 16. Lung Cancer Case Studies
 Figure 17. Others Case Studies
 Figure 18. Personalized Medicine for Cancer Report Years Considered
 Figure 19. Global Personalized Medicine for Cancer Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 20. Global Personalized Medicine for Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 21. Global Personalized Medicine for Cancer Market Share by Region: 2024 VS 2031
 Figure 22. Global Personalized Medicine for Cancer Market Share by Players in 2024
 Figure 23. Global Top Personalized Medicine for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine for Cancer as of 2024)
 Figure 24. The Top 10 and 5 Players Market Share by Personalized Medicine for Cancer Revenue in 2024
 Figure 25. North America Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. North America Personalized Medicine for Cancer Market Share by Country (2020-2031)
 Figure 27. United States Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Canada Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Europe Personalized Medicine for Cancer Market Share by Country (2020-2031)
 Figure 31. Germany Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. France Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. U.K. Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Italy Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Russia Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Nordic Countries Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Personalized Medicine for Cancer Market Share by Region (2020-2031)
 Figure 39. China Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Japan Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. South Korea Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. India Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Australia Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Latin America Personalized Medicine for Cancer Market Share by Country (2020-2031)
 Figure 47. Mexico Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Brazil Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Middle East & Africa Personalized Medicine for Cancer Market Share by Country (2020-2031)
 Figure 51. Turkey Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. UAE Personalized Medicine for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. Bayer Revenue Growth Rate in Personalized Medicine for Cancer Business (2020-2025)
 Figure 55. GlaxoSmithKline Revenue Growth Rate in Personalized Medicine for Cancer Business (2020-2025)
 Figure 56. Novartis Revenue Growth Rate in Personalized Medicine for Cancer Business (2020-2025)
 Figure 57. Sanofi Revenue Growth Rate in Personalized Medicine for Cancer Business (2020-2025)
 Figure 58. Pfizer Revenue Growth Rate in Personalized Medicine for Cancer Business (2020-2025)
 Figure 59. Amgen Revenue Growth Rate in Personalized Medicine for Cancer Business (2020-2025)
 Figure 60. Merck Revenue Growth Rate in Personalized Medicine for Cancer Business (2020-2025)
 Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Personalized Medicine for Cancer Business (2020-2025)
 Figure 62. Ariad Pharmaceuticals (Takeda) Revenue Growth Rate in Personalized Medicine for Cancer Business (2020-2025)
 Figure 63. Eli Lilly Revenue Growth Rate in Personalized Medicine for Cancer Business (2020-2025)
 Figure 64. Roche Revenue Growth Rate in Personalized Medicine for Cancer Business (2020-2025)
 Figure 65. Boehringer Ingelheim Revenue Growth Rate in Personalized Medicine for Cancer Business (2020-2025)
 Figure 66. Johnson and Johnson Revenue Growth Rate in Personalized Medicine for Cancer Business (2020-2025)
 Figure 67. Teva Pharmaceuticals Revenue Growth Rate in Personalized Medicine for Cancer Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Precision Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024
Global Cancer Diagnostics Service Market Research Report 2025
Global Targeted Drugs for Breast Cancer Market Research Report 2024
Global Kidney Cancer Diagnosis Market Research Report 2025
Global Gynecological Cancers Drug Market Research Report 2025
Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Small Molecule Cancer Drug Market Research Report 2025
Oncology Anti cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Generics Market
Molecular Diagnosis of Tumors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Next Generation Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Personalizing Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intratumoral Cancer Therapies Market Research Report 2025
Precision Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Advanced Prostate Cancer Drug Market Research Report 2025
Global Cancer Tissue Diagnostics Market Research Report 2024

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H16852
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K16619
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30U16301
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2G16953
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions